Synthesis of Analogues of (+)-Gomphoside, a Potent HIF-1 Inhibitor and Cardenolide

Author:

Cuny Eckehard1

Affiliation:

1. Clemens-Schöpf-Institute of Organic Chemistry and Biochemistry, Darmstadt Technical University, Alarich-Weiss-Straße 4, 64287 Darmstadt, Germany

Abstract

The milkweed bush Gomphocarpus fruticosus R.Br. found in Australia contains the steroidal glycoside (+)-gomphoside, its derivatives (-)-3'-dehydrogomphoside and (+)-3'- epi-gomphoside, as well as other glycoside compounds. The key structural features of these unique herbal agents are bislinked steroid to sugar linkages. (+)-Gomphoside is an extremely potent cardenolide and highly effective Hypoxia-Inducible Factor (HIF)-1 inhibitor. In addition, (+)-gomphoside exhibits strong cytotoxicity on human breast cancer cell lines. The syntheses of (+)-gomphoside analogues with modified steroidal D rings are described here. The syntheses started with glycosylation of (+)-(2α,3β,5α)-2,3-cholestanediol with benzoylated 2-keto sugar bromides, promoted by silver carbonate. Two regioisomeric glycosides with bent up and bent down ring anellation geometry were obtained, because of the two hydroxyl groups in the diol. Modification of the sugar ring of these glycosides by base-induced elimination of benzoic acid yielded (-)-3'-dehydrogomphoside analogues. The analogues of (+)-gomphoside and (+)-3'- epi-gomphoside were then obtained by stereoselective reduction of the 3'-carbonyl function. Compared to natural (+)-gomphoside, these analogues have the following unique structural features: a steroidal D ring with C8H17-alkyl chain instead of an exocyclic butenolide moiety, a different configuration at bridgehead carbon-14, and lack of a hydroxyl group at this position. The resulting altered chemical properties make them interesting structures for pharmacological evaluation and they are potentially suitable candidates for the development of new inhibitors in cancer therapy.

Publisher

SAGE Publications

Subject

Complementary and alternative medicine,Plant Science,Drug Discovery,Pharmacology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3